Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00106899 · ClinicalTrials.gov registry record
ADNI: Alzheimer's Disease Neuroimaging Initiative
A clinical trial, sponsored by Alzheimer's Disease Cooperative Study (ADCS).
- Completed
- Registry status
- 818
- Enrollment target
NCT00106899 is a clinical trial that has completed, run by Alzheimer's Disease Cooperative Study (ADCS). The registered enrollment target is 818 participants.
The verdict
NCT00106899 has completed, sponsored by Alzheimer's Disease Cooperative Study (ADCS).
- COMPLETED
- Registry status
- 818 participants
- Enrollment target
Study Summary
The purpose of this study is to examine how brain imaging technology can be used with other tests to measure the progression of mild cognitive impairment (MCI) and early Alzheimer's disease (AD). This information will aid future clinical trials by providing a standard assessment tool to measure the effects of treatments being studied.
Interventions
- PROCEDURE Magnetic Resonance Imaging (MRI)
- PROCEDURE Positron Emission Tomography (PET)
- PROCEDURE Lumbar Puncture (LP)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 818 participants |
| Start Date | 2005-07 |
| Est. Completion | 2011-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00106899
The ClinicalTrials.gov registry entry for NCT00106899 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 818 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Alzheimer's Disease Cooperative Study (ADCS), which has 10 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Magnetic Resonance Imaging (MRI) is the first listed.
NCT00106899 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00106899 about?
NCT00106899 is a clinical study titled "ADNI: Alzheimer's Disease Neuroimaging Initiative". The purpose of this study is to examine how brain imaging technology can be used with other tests to measure the progression of mild cognitive impairment (MCI) and early Alzheimer's disease (AD). This information will aid future clinical trials by providing a standard assessment tool to measure the ...
What is the current status of trial NCT00106899?
This trial is currently completed. The enrollment target is 818 participants. The study started on 2005-07. Estimated completion is 2011-06.
What interventions are being tested in trial NCT00106899?
The interventions under investigation include: Magnetic Resonance Imaging (MRI) (PROCEDURE), Positron Emission Tomography (PET) (PROCEDURE), Lumbar Puncture (LP) (PROCEDURE).
Who is sponsoring clinical trial NCT00106899?
This trial is sponsored by Alzheimer's Disease Cooperative Study (ADCS), which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.